Concepedia

Publication | Open Access

Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas

DOIFull Paper Access

19

Citations

34

References

2020

Year

Geraldine O’Sullivan Coyne, Shivaani Kummar, Robert Meehan, T. Khanh, Jerry M. Collins, Larry Anderson, Kazusa Ishii, Naoko Takebe, Jennifer Zlott, Lamin Juwara,
Oncotarget

Abstract

The combination of TRC 102 with temozolomide is active, with 4 of 51 patients experiencing a partial response and 13 of 51 experiencing stable disease, and the side effect profile is manageable.

References

YearCitations

Page 1